Improve Brain Health & Memory | Cerefolin Brain Wellness™

Supporting your brain today for a better tomorrow. Order now!

Female and male in their 60's smiling at camera. Cerefolin Brain Wellness™ bottle under couple — Neurologist Recommended^5*

Targeted Nutrition to Slow Cognitive Decline and Brain Shrinkage

Improve Brain Health, Memory, Focus & Concentration

Shop Brain Wellness

Improves Memory

Improves Concentration

Slows Cognitive Decline

Improves Focus

Improves Brain Health

Slows Brain Atrophy

Improves Memory

Improves Concentration

Slows Cognitive Decline

Improves Focus

Improves Brain Health

Slows Brain Atrophy

Dual Action Formula

Targeted nutrition for Mild Cognitive Impairment (MCI).

Improves

Brain Health

Cerefolin Brain Wellness™ helps support overall brain function by providing essential nutrients that aid in reducing harmful homocysteine levels, which can negatively impact brain health.^3*
Memory & Focus

Individuals taking Cerefolin Brain Wellness™ showed improvement in memory and ability to focus on daily activities.^4*
Concentration

Cerefolin Brain Wellness™ helped people maintain attention and stay on task, which are essential for completing daily tasks and decision-making processes.^4*

Slows

Cognitive Decline

Long-term use of Cerefolin Brain Wellness™ was associated with a significantly slower rate of cognitive decline, especially in individuals with mild cognitive impairment.^2*
Brain Atrophy

Research shows that people who have MCI and elevated homocysteine levels had slower brain shrinkage, which helps keep their memory, thinking skills and overall brain health strong.^1*

Use under medical supervision

Cerefolin Brain Wellness™ 30 count bottle with white circles behind it.

Trust in the Results

Neurologists recommend Cerefolin Brain Wellness™*. Starting early can help protect your brain cells, slow the loss of brain function, and improve your overall quality of life.^1-3

Learn More

Clinically Proven To

Slow the rate of brain shrinkage by 11.2x^1*

Strong Loyalty

94% who used product for 90 days said they planned to continue⁴*

Free From

Gluten, dyes, sugar, sodium, caffeine, preservatives, GMOs, titanium dioxide and major food allergens*

You may start seeing improvements in as little as 45 days.

How do I know if I or a loved one have Mild Cognitive Impairment (MCI)?

Learn more about the signs of MCI and how you can help protect your brain health.

Disclaimers

Cerefolin Brain Wellness™ is a targeted nutrition product for the clinical dietary management of mild cognitive impairment with hyperhomocysteinemia and is specially formulated to meet the distinctive nutritional requirements for this condition. Use only under medical supervision.

* Cerefolin Brain Wellness™, formerly known and studied as CerefolinNAC®, is the same trusted and effective product that is now free from major allergens (milk, eggs, fish, shellfish, tree nuts, peanuts, wheat, sesame and soy), dyes, and colorants.

† By submitting this information, I hereby give Alfasigma USA, Inc. authorization to release, reproduce, use or distribute information about me, in original or modified form, for promotional and educational purposes in all forms of media, including print, broadcast or Internet. This information may include my medical information if I choose to submit any. I understand my information may be shared with a third party working on Alfasigma USA, Inc.’s behalf for promotional or educational purposes. I also understand that I may be contacted by this third party or Alfasigma USA, Inc. for more information.

^†† This product should be taken under medical supervision, and you should consult your healthcare provider before taking this for mild cognitive impairment.

References

Shankle WR, et al. J Alzheimer’s Dis. 2016 Oct 4;54(3):1073-1084
Shankle WR, et al. J Aging Res Clin Prac. 2013
Hara J, et al. Nutr Health Aging. 2015
Alfasigma USA. Data on File. PLUS Program: Patient Survey Results 2012. USA
Data on file. Support data 2019-2024. Alfasigma USA.
Chan A, et al. J Nutr Health Aging 2008;12(4):252-61.
de Jager CA. et al. Int J Geriatr Psychiatry. 2012 Jun:27(6):592-600.
Merrill E, et al. Am. J. Epidemiol. 2005 Oct;162(7):644-53.
Altern Med Rev 2000 Oct;5(5):467-71.
de Jager CA. Neurobiol Aging 2014;35(suppl 2):535-9.
Atkuri KR, et al. Curr Opin Pharmacol. 2007. 2007
N-acetylcysteine. Monograph. Alt Med Rev. 2000
Antoniades C, et al. Circulation. 2006.
Calderón-Ospina CA, et al. CNS Neurosci Ther. 2020.
Kimura, A.M et al. Alzheimer’s Dement. 2021.
Rogers JD, et al. Arch Neurol. 2003 Jan;60(1):59-64.
Smith AD, et al. J Alzheimer’s Dis.
Seshadri S, et al. N Engl J Med. 2002.
Yao Y, et al. J Geriatr Cardiol. 2017.
Diaz-Arrastia R, et al. Arch Neurol. 2000.
Keller, A.C., et al. J. Appl. Physiol. 2019.
Zhu Z, et al. Climacteric. 2020.
Estrada, D.A. et al. Am. J. Hematol. 2001.
Luzzi S, et al. Biomedicines. 2022.
Diekman, M. J. M., et al. Clin. Endocrinol. (Oxf) 2001.
Paknahad Z, et al. Int J Prev Med. 2012.
Desouza, C, et al. Drugs. 2002.
P. S. Myles et al. Br. J. Anaesth. 2008.
Fallah S, et al. J Clin Lab Anal. 2012.
Lerman, et al. AJMS., 2022.
Troen AM, et al. Proc Natl Acad Sci U S A. 2003.
Haj Mouhamed D, et al. Clin Chem Lab Med. 2011.

ALUSA-01273

Targeted Nutrition to Slow Cognitive Decline and Brain Shrinkage